Katherine R. Kozak

Medicine · Health Sciences

34h-index4.1kcitations131works7.22yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HER2/EGFR in Cancer Research(79), Monoclonal and Polyclonal Antibodies Research(71), Cell Adhesion Molecules Research(22), CAR-T cell therapy research(17), Electron Spin Resonance Studies(10)

Publications131 total

AI-based analysis of label-free live cell imaging of T-cell mediated tumor killing assay enables competitive and robust hit calling
SLAS DISCOVERY·2026Open Access
Mechanistic Characterization of the Potency of THIOMAB Antibody–Drug Conjugates Targeting <i>Staphylococcus aureus</i> and ETbR-Expressing Tumor Cells Using Quantitative LC-MS/MS Analysis of Intracellular Drug Accumulation
Bioconjugate Chemistry·2025
A search for new compounds for candidosis treatment – screening of Antarctic bacteria from the IBA collection
New Biotechnology·2025Open Access
NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunity
Cancer Immunology Immunotherapy·2024· 21 citedOpen Access
On Demand Bioorthogonal Switching of an Antibody-Conjugated SPECT Probe to a Cytotoxic Payload: from Imaging to Therapy
Journal of the American Chemical Society·2024· 15 cited
Supplementary Table 2 from An Antimesothelin-Monomethyl Auristatin E Conjugate with Potent Antitumor Activity in Ovarian, Pancreatic, and Mesothelioma Models
2023Open Access
Data from An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody–Drug Conjugate for the Treatment of Hormone Receptor–Positive Breast Cancer
2023Open Access
Supplementary Figure 2 from An Antimesothelin-Monomethyl Auristatin E Conjugate with Potent Antitumor Activity in Ovarian, Pancreatic, and Mesothelioma Models
2023Open Access
Supplementary Figure 1 from DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody–Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma
2023Open Access
Figures S1-S4, Tables S1-S2 from An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody–Drug Conjugate for the Treatment of Hormone Receptor–Positive Breast Cancer
2023Open Access
Data from An Antimesothelin-Monomethyl Auristatin E Conjugate with Potent Antitumor Activity in Ovarian, Pancreatic, and Mesothelioma Models
2023Open Access
Data from Calicheamicin Antibody–Drug Conjugates with Improved Properties
2023Open Access
Data from Intratumoral Payload Concentration Correlates with the Activity of Antibody–Drug Conjugates
2023Open Access
Supplementary Figure 2 from An Antimesothelin-Monomethyl Auristatin E Conjugate with Potent Antitumor Activity in Ovarian, Pancreatic, and Mesothelioma Models
2023Open Access
Supplementary Table 1 from An Antimesothelin-Monomethyl Auristatin E Conjugate with Potent Antitumor Activity in Ovarian, Pancreatic, and Mesothelioma Models
2023Open Access
Supplementary Figure 1 from An Antimesothelin-Monomethyl Auristatin E Conjugate with Potent Antitumor Activity in Ovarian, Pancreatic, and Mesothelioma Models
2023Open Access
Supplementary Materials and Methods and Supplementary Figure Legends from An Antimesothelin-Monomethyl Auristatin E Conjugate with Potent Antitumor Activity in Ovarian, Pancreatic, and Mesothelioma Models
2023Open Access
Data from Effects of Anti-VEGF on Pharmacokinetics, Biodistribution, and Tumor Penetration of Trastuzumab in a Preclinical Breast Cancer Model
2023Open Access
Supplementary Figure 4 from An Antimesothelin-Monomethyl Auristatin E Conjugate with Potent Antitumor Activity in Ovarian, Pancreatic, and Mesothelioma Models
2023Open Access
Data from DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody–Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Thomas H. Pillow(25), Shang‐Fan Yu(25), Donglu Zhang(16), Keyang Xu(16), Jack Sadowsky(15), Josefa Chuh(14), Peter S. Dragovich(14), Gail D. Lewis Phillips(14), Josefa dela Cruz-Chuh(13), John Wai(12), Zijin Xu(12), Aimee Fourie-O’Donohue(12), Andrew G. Polson(11), Geoffrey Del Rosario(10), BinQing Wei(10), Rachana Ohri(10), Rebecca K. Rowntree(9), Carl Ng(9), Guangmin Li(9), Dian Su(9)